中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:(Mengya DONG)

1.Comparative proteomics study of different processing technology for pilose antler using iTRAQ technology coupled with 2D LC-MS.

Mengya JIN ; Ling DONG ; Yuanming LUO ; Li YU ; Mei MO ; Chengbo HOU ; Zhiyuan LI

Acta Pharmaceutica Sinica 2015;50(12):1637-44

2.Determination on Solubility and Oil-water Partition Coefficient of Main Active Components in Ge-Gen Qin-Lian Tablets

Meiling ZHU ; Yang LIU ; Yanfei CAO ; Li WEI ; Mingmin TANG ; Wenning YANG ; Chengbo HOU ; Baoxia WEI ; Mengya JIN ; Ling DONG

World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(12):2686-2691

3.Relationship between preoperative serum bilirubin concentration and postoperative delirium in patients undergoing knee or hip replacement

Shuhui HUA ; Mengya ZHANG ; Shanling XU ; Yunchao YANG ; Haoran ZHANG ; Chuan LI ; Yanan LIN ; Rui DONG ; Hongyan GONG ; Xu LIN ; Yanlin BI ; Bin WANG

Chinese Journal of Anesthesiology 2024;44(3):286-291

4.Pathogenesis and therapeutic targets of inflammatory cardiomyopathy based on bioinformatics analysis

Hongjun YOU ; Qianqian ZHAO ; Shuting REN ; Xiling SHOU ; Jiayu DIAO ; Mengya DONG

Journal of Xi'an Jiaotong University(Medical Sciences) 2021;42(6):829-836

5.Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease.

Xiaoyu DONG ; Yiting FENG ; Dongqin XU ; Mengya ZHANG ; Xiao WEN ; Wenhao ZHAO ; Qintong HU ; Qinyong ZHANG ; Hui FU ; Jie PING

Acta Pharmaceutica Sinica B 2023;13(1):142-156

6.Efficacy of hepatic arterial infusion chemotherapy and its multimodality therapeutic regimens in treatment of patients with advanced hepatocellular carcinoma and related prognostic factors

Wencong DAI ; Mengya ZANG ; Guosheng YUAN ; Qi LI ; Rong LI ; Wenli LI ; Shuyu DONG ; Jinzhang CHEN

Journal of Clinical Hepatology 2023;39(7):1592-1599

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO